ARCHIVES

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

UT System (Again) Directs DePinho to Cure MD Anderson Faculty Angst

November 7, 2014

DCPC Forms Decision Network To oversee Chemoprevention

July 16, 1993

Interest Picks Up In SBIR, NCI May Not Gave To Face Choice of Giving Money Back Or Paying to 500 Level

November 23, 1984

Automated Thermography System Said to Be As Good As Mammography Developed for Mass Screening

July 4, 1980

DCE director Adamson To Retire August 31

June 3, 1994

Rabson’s Group Hears Suggestions On Carcinogenesis

November 25, 1977